Evidence map›Paper›PMID 23157448›Full record

ReviewAnnual review of clinical psychology2013

How can we use our knowledge of alcohol-tobacco interactions to reduce alcohol use?

Sherry A McKee, Andrea H Weinberger

Abstract readReview
In one paragraph

Review in Annual review of clinical psychology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. An Evaluation of Potential Unintended Consequences of a Nicotine Product Standard: A Focus on Drinking History and Outcomes.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Trial
  7. Trial
  8. Trial
  9. Trial
  10. The Impact of Smoking Very Low Nicotine Content Cigarettes on Alcohol Use.Alcoholism, clinical and experimental research · 2016
    Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Article
  17. Who is alcohol cue-reactive? A machine learning approach.Alcohol and alcoholism (Oxford, Oxfordshire) · 2025
    Article
  18. Article
  19. Article
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sherry A McKeeDepartment of Psychiatry and Women's Health Research at Yale, Yale University School of Medicine, and Cancer Prevention and Control Research Program, Yale Cancer Center, New Haven, Connecticut 06519, USA. sherry.mckee@yale.edu
Andrea H Weinberger

Funding

Yale SCOR on Gender-Sensitive Treatment for Tobacco DependenceP50DA033945 · NIDA · YALE UNIVERSITY · PI MCKEE, SHERRY ANN · 2012 to 2017
$6.5M
Modeling Stress-Precipitated Smoking Lapse for Medication Development (9 of 14)RL1DA024857 · NIDA · YALE UNIVERSITY · PI MCKEE, SHERRY ANN · 2007 to 2011
$1.3M
Dose ranging study of varenicline on human alcohol self-administration behaviorR01AA017976 · NIAAA · YALE UNIVERSITY · PI MCKEE, SHERRY ANN · 2009 to 2011
$1.0M
Does Tobacco Legislation Reduce Alcohol Consumption?R21AA018273 · NIAAA · YALE UNIVERSITY · PI HYLAND, ANDREW, MCKEE, SHERRY ANN · 2010 to 2011
$502k
Gender differences in the association of depression to transitions in smoking.R03DA027052 · NIDA · YALE UNIVERSITY · PI WEINBERGER, ANDREA HOPE · 2010 to 2011
$139k
NIAAA NIH HHS R01 AA017976NIAAA NIH HHS R01AA017976NIAAA NIH HHS R21 AA018273NIAAA NIH HHS R21AA018273NIDA NIH HHS P50 DA033945NIDA NIH HHS P50DA033945NIDA NIH HHS R03 DA027052NIDA NIH HHS R03DA027052NIDA NIH HHS RL1 DA024857NIDA NIH HHS RL1DA024857
6 · The paper itself

Abstract

Currently, 8.5% of the US population meets criteria for alcohol use disorders, with a total cost to the US economy estimated at $234 billion per year. Alcohol and tobacco use share a high degree of comorbidity and interact across many levels of analysis. This review begins by highlighting alcohol and tobacco comorbidity and presenting evidence that tobacco increases the risk for alcohol misuse and likely has a causal role in this relationship. We then discuss how knowledge of alcohol and tobacco interactions can be used to reduce alcohol use, focusing on whether (a) smoking status can be used as a clinical indicator for alcohol misuse, (b) tobacco policies reduce alcohol use, and (c) nicotinic-based medications can be used to treat alcohol use disorders.

Indexed as

ComorbidityAlcoholismHumansTobacco Use Disorder

Identifiers

PMID23157448
PMCPMC3651830

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.